GI
LXRX icon

GAMCO Investors’s Lexicon Pharmaceuticals LXRX Stock Holding History

GAMCO Investors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-22,000
Closed -$138K – 928
2019
Q2 		$138K Hold
22,000
– – ﹤0.01% 899
2019
Q1 		$122K Buy
22,000
+2,000
+10% +$12.1K ﹤0.01% 828
2018
Q4 		$133K Hold
20,000
– – ﹤0.01% 776
2018
Q3 		$213K Buy
20,000
+4,000
+25% +$45.8K ﹤0.01% 795
2018
Q2 		$192K Buy
16,000
+800
+5% +$8.18K ﹤0.01% 821
2018
Q1 		$130K Buy
15,200
+600
+4% +$5.55K ﹤0.01% 818
2017
Q4 		$144K Hold
14,600
– – ﹤0.01% 817
2017
Q3 		$179K Hold
14,600
– – ﹤0.01% 814
2017
Q2 		$240K Hold
14,600
– – ﹤0.01% 784
2017
Q1 		$209K Hold
14,600
– – ﹤0.01% 789
2016
Q4 		$202K Hold
14,600
– – ﹤0.01% 775
2016
Q3 		$264K Sell
14,600
-1,500
-9% -$24.1K ﹤0.01% 751
2016
Q2 		$231K Hold
16,100
– – ﹤0.01% 768
2016
Q1 		$192K Hold
16,100
– – ﹤0.01% 763
2015
Q4 		$214K Buy
16,100
+1,815
+13% +$22.3K ﹤0.01% 762
2015
Q3 		$153K Hold
14,285
– – ﹤0.01% 795
2015
Q2 		$115K Sell
14,285
-744
-5% -$5.46K ﹤0.01% 812
2015
Q1 		$99K Hold
15,029
– – ﹤0.01% 820
2014
Q4 		$96K Sell
15,029
-7,857
-34% -$63.3K ﹤0.01% 846
2014
Q3 		$226K Hold
22,886
– – ﹤0.01% 821
2014
Q2 		$258K Buy
22,886
+2,429
+12% +$26.1K ﹤0.01% 811
2014
Q1 		$248K Hold
20,457
– – ﹤0.01% 786
2013
Q4 		$258K Hold
20,457
– – ﹤0.01% 770
2013
Q3 		$341K Hold
20,457
– – ﹤0.01% 727
2013
Q2 		$311K Buy
+20,457
New +$311K ﹤0.01% 720

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAMCO Investors's LXRX Position: Q3 2019 in Review

GAMCO Investors sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2019, closing a stake of 22,000 shares — an estimated $138K sold.

GAMCO Investors first reported a position in LXRX in Q2 2013 and held it in 25 quarters. The position peaked at $341K in Q3 2013. 103 funds tracked by Wall St. Rank hold LXRX as of Q3 2019.

  • GAMCO Investors reported no remaining Lexicon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • GAMCO Investors sold 22,000 Lexicon Pharmaceuticals shares in Q3 2019, an estimated $138K.
  • GAMCO Investors first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • GAMCO Investors's Lexicon Pharmaceuticals position peaked at $341K in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2019.

Based on GAMCO Investors's 13F filing for Q3 2019, filed 1 Nov 2019.